Deng-Fu Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Deng-Fu Guo has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
Isabelle Chenier
From the Research Centre (D-F.G., I.C., J.L.L., J.S.D.C., P.H., J.T.), Centre hospitalier de l’Université de Montréal, Hôtel-Dieu, Quebec, Canada; Department of Nephrology (X.M.C.), General Hospital of the People’s Liberation Army, Beijing, People’s Republic of China; Department of Medicine, Neuroscience, and Cell & Molecular Biology Program (D.H.W.), Michigan State University, East Lansing; and the Department of Biochemistry (T.I.), School of Medicine, Vanderbilt University, Nashville, Tenn
3 shared publicationsTadashi Inagami
From the Research Centre (D-F.G., I.C., J.L.L., J.S.D.C., P.H., J.T.), Centre hospitalier de l’Université de Montréal, Hôtel-Dieu, Quebec, Canada; Department of Nephrology (X.M.C.), General Hospital of the People’s Liberation Army, Beijing, People’s Republic of China; Department of Medicine, Neuroscience, and Cell & Molecular Biology Program (D.H.W.), Michigan State University, East Lansing; and the Department of Biochemistry (T.I.), School of Medicine, Vanderbilt University, Nashville, Tenn
3 shared publicationsPavel Hamet
From the Research Centre (D-F.G., I.C., J.L.L., J.S.D.C., P.H., J.T.), Centre hospitalier de l’Université de Montréal, Hôtel-Dieu, Quebec, Canada; Department of Nephrology (X.M.C.), General Hospital of the People’s Liberation Army, Beijing, People’s Republic of China; Department of Medicine, Neuroscience, and Cell & Molecular Biology Program (D.H.W.), Michigan State University, East Lansing; and the Department of Biochemistry (T.I.), School of Medicine, Vanderbilt University, Nashville, Tenn
2 shared publicationsValerie Tardif
2 shared publicationsA. Carretero
1 shared publicationA. Meseguer
1 shared publication
Latest Publications
- Open Access
- 1 September 2006
- Published by Wolters Kluwer Health in Hypertension
- Vol. 48 (3) , 453-459
Development of Hypertension and Kidney Hypertrophy in Transgenic Mice Overexpressing ARAP1 Gene in the Kidney
Angiotensin II regulates blood pressure via activation of the type 1 receptor. We previously identified a novel angiotensin II type 1 receptor–associated protein and demonstrated that it promotes receptor recycling to the plasma membrane. To delineate the pathophysiological function of the ARAP1 in the kidneys, we generated transgenic mice that overexpress rat ARAP1 cDNA specifically in proximal tubules and tested the hypothesis that proximal tubule-specific overexpression of ARAP1 causes hypertension. Two lines of male transgenic mice, 650 and 670, displayed kidney-specific transgene expression. Systolic blood pressure was significantly elevated by &20 to 25 mm Hg in these lines of mice at 20 weeks of age compared with their nontransgenic litter mates. Urine volume, but not water intake, was significantly decreased in both lines compared with nontransgenic controls. The kidney/body weight ratio was significantly increased in both lines compared with their nontransgenic litter mates at 12 and 20 weeks of age. In contrast, no difference was observed in the ratio of brain, spleen, heart, and testis to body weight between male transgenic and nontransgenic animals. Inhibitions of the renin–angiotensin system completely normalized the systolic blood pressure of transgenic mice. Moreover, low salt intake prevented the development of hypertension, whereas high salt intake exacerbated the increase in blood pressure in transgenic mice. Therefore, our data show that proximal tubule-specific overexpression of ARAP1 leads to hypertension, suggesting that renal ARAP1 plays an important role in the regulation of blood pressure and renal function via activation of the intrarenal renin–angiotensin system.
- 1 September 2006
- Published by Wolters Kluwer Health in Hypertension
- Vol. 48 (3) , 453-459
Open AccessDevelopment of Hypertension and Kidney Hypertrophy in Transgenic Mice Overexpressing ARAP1 Gene in the Kidney
Angiotensin II regulates blood pressure via activation of the type 1 receptor. We previously identified a novel angiotensin II type 1 receptor–associated protein and demonstrated that it promotes receptor recycling to the plasma membrane. To delineate the pathophysiological function of the ARAP1 in the kidneys, we generated transgenic mice that overexpress rat ARAP1 cDNA specifically in proximal tubules and tested the hypothesis that proximal tubule-specific overexpression of ARAP1 causes hypertension. Two lines of male transgenic mice, 650 and 670, displayed kidney-specific transgene expression. Systolic blood pressure was significantly elevated by &20 to 25 mm Hg in these lines of mice at 20 weeks of age compared with their nontransgenic litter mates. Urine volume, but not water intake, was significantly decreased in both lines compared with nontransgenic controls. The kidney/body weight ratio was significantly increased in both lines compared with their nontransgenic litter mates at 12 and 20 weeks of age. In contrast, no difference was observed in the ratio of brain, spleen, heart, and testis to body weight between male transgenic and nontransgenic animals. Inhibitions of the renin–angiotensin system completely normalized the systolic blood pressure of transgenic mice. Moreover, low salt intake prevented the development of hypertension, whereas high salt intake exacerbated the increase in blood pressure in transgenic mice. Therefore, our data show that proximal tubule-specific overexpression of ARAP1 leads to hypertension, suggesting that renal ARAP1 plays an important role in the regulation of blood pressure and renal function via activation of the intrarenal renin–angiotensin system.
- Open Access
- 1 May 2004
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (20) , 21109-21120
A Novel Angiotensin II Type 1 Receptor-associated Protein Induces Cellular Hypertrophy in Rat Vascular Smooth Muscle and Renal Proximal Tubular Cells
- 1 May 2004
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (20) , 21109-21120
Open AccessA Novel Angiotensin II Type 1 Receptor-associated Protein Induces Cellular Hypertrophy in Rat Vascular Smooth Muscle and Renal Proximal Tubular Cells
- 1 October 2003
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 310 (4) , 1254-1265
Type 1 angiotensin II receptor-associated protein ARAP1 binds and recycles the receptor to the plasma membrane
- 1 October 2003
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 310 (4) , 1254-1265
Type 1 angiotensin II receptor-associated protein ARAP1 binds and recycles the receptor to the plasma membrane
- Open Access
- 1 September 2001
- Published by Springer Nature in Cell Research
- Vol. 11 (3) , 165-180
The angiotensin II type 1 receptor and receptor-associated proteins
The mechanisms of regulation, activation and signal transduction of the angiotensin II (Ang II) type 1 (AT1) receptor have been studied extensively in the decade after its cloning. The AT1 receptor is a major component of the renin-angiotensin system (RAS). It mediates the classical biological actions of Ang II. Among the structures required for regulation and activation of the receptor, its carboxyl-terminal region plays crucial roles in receptor internalization, desensitization and phosphorylation. The mechanisms involved in heterotrimeric G-protein coupling to the receptor, activation of the downstream signaling pathway by G proteins and the Ang II signal transduction pathways leading to specific cellular responses are discussed. In addition, recent work on the identification and characterization of novel proteins associated with carboxyl-terminus of the AT1 receptor is presented. These novel proteins will advance our understanding of how the receptor is internalized and recycled as they provide molecular mechanisms for the activation and regulation of G-protein-coupled receptors.
- 1 September 2001
- Published by Springer Nature in Cell Research
- Vol. 11 (3) , 165-180
Open AccessThe angiotensin II type 1 receptor and receptor-associated proteins
The mechanisms of regulation, activation and signal transduction of the angiotensin II (Ang II) type 1 (AT1) receptor have been studied extensively in the decade after its cloning. The AT1 receptor is a major component of the renin-angiotensin system (RAS). It mediates the classical biological actions of Ang II. Among the structures required for regulation and activation of the receptor, its carboxyl-terminal region plays crucial roles in receptor internalization, desensitization and phosphorylation. The mechanisms involved in heterotrimeric G-protein coupling to the receptor, activation of the downstream signaling pathway by G proteins and the Ang II signal transduction pathways leading to specific cellular responses are discussed. In addition, recent work on the identification and characterization of novel proteins associated with carboxyl-terminus of the AT1 receptor is presented. These novel proteins will advance our understanding of how the receptor is internalized and recycled as they provide molecular mechanisms for the activation and regulation of G-protein-coupled receptors.